NCT02790788View on ClinicalTrials.gov

Physiologic Effects of Steroids in Cardiac Arrest

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

November 4, 2016

Primary Completion Date

May 22, 2018

Study Completion Date

August 11, 2018

Conditions
Inhospital Cardiac Arrest
Interventions
DRUG

Methylprednisolone; hydrocortisone

Methylprednisolone 40 mg during resuscitation and stress-dose hydrocortisone for postresuscitation shock

DRUG

Saline Placebo

Saline placebo during resuscitation and during the postresuscitation phase.

Trial Locations (2)

GR-10675

Department of Intensive Care Medicine, Evaggelismos Hospital, Athens

GR-41110

Larisa University General Hospital, Larissa

All Listed Sponsors
collaborator

University of Thessaly

OTHER

lead

University of Athens

OTHER

NCT02790788 - Physiologic Effects of Steroids in Cardiac Arrest | Biotech Hunter | Biotech Hunter